首页> 外文期刊>The Professional Medical Journal >Cost effectiveness of tunneled double lumen to non-tunnel double lumen dialysis catheters.
【24h】

Cost effectiveness of tunneled double lumen to non-tunnel double lumen dialysis catheters.

机译:隧道式双腔至非隧道式双腔透析导管的成本效益。

获取原文
           

摘要

Objectives: To ascertain the cost-effectiveness of tunneled catheters to nontunneledcatheter in dialysis patients of a tertiary care hospital. Study Design: Retrospectivecross-sectional study. Study Design: Department of Nephrology, Pak Emirates Military HospitalRawalpindi. Period: Jan 2016 to Jan 2019. Material & Methods: The sample populationcomprised of 500 patients, being divided into two groups and followed over a period of 03 yrs.Group A had tunneled double lumen and group B had non tunneled double lumen. Dialysiswas started on the same day in both groups. Both groups were compared in terms of costeffectiveness. Cost effectiveness included price of catheter, procedure cost, treatment ofinfection (if any), and change of catheter in case of catheter malfunction. The amount spent oneach patient was added and then an average was calculated. Results: Out of 600 patients, 300were in group A and 300 patients were in group B. The two groups were analogous in gender(male: 52.8% vs 57.8%, p=0.35)age (41 years vs 49 yrs, p=0.71) hypertension and diabetes asthe main causes of ESRD (51% vs 39%, p=0.08 and 32% vs 34%, p=0.38, respectively). Totalincurred cost of tunneled double lumen was Rs.19000.00, with average infection free patencytime being three months during which Arteriovenous fistula formed. In comparison, non-tunneleddouble lumen in 300 patients, average cost incurred was Rs.30000.00 including cost incurredon treating sepsis and in two –three insertions in few cases . There was no procedure relatedmortality. Conclusion: The cost-effectiveness of Tunneled double lumen catheters and clinicalbenefit of reduction in patency failures and also access related infections make them the firstchoice for dialysis patients in majority of dialysis centers of our country but large randomizedcontrol trials needed as the sample size quite less to detect a difference from the newer agents.
机译:目的:确定三级医院透析患者的非尿道导管隧道导管的成本效益。研究设计:回顾性横断面研究。研究设计:北阿联酋军事医院肾脏科Rawalpindi。时间:2016年1月至2019年1月。材料与方法:样本人群为500名患者,分为两组,随访时间为03年。A组为双管腔,B组为非管腔。两组均于同一天开始透析。比较两组的成本效益。成本效益包括导管价格,手术成本,感染(如果有)的治疗以及导管发生故障时更换导管。添加在每个患者身上花费的金额,然后计算平均值。结果:600例患者中,A组300例,B组300例。两组的性别相似(男性:52.8%vs 57.8%,p = 0.35)(41岁vs 49岁,p = 0.71)。 )高血压和糖尿病是ESRD的主要原因(分别为51%vs 39%,p = 0.08和32%vs 34%,p = 0.38)。穿隧双腔的总费用为19000.00卢比,平均无感染通畅时间为动静脉瘘形成三个月。相比之下,非隧道双腔管治疗的300例患者的平均费用为30000.00卢比,包括败血症的治疗费用和少数情况下分两次进行的三次插管。没有与手术相关的死亡率。结论:隧道式双腔导管的成本效益以及减少通畅性衰竭以及获得相关感染的临床益处使它们成为我国大多数透析中心的透析患者的首选,但由于样本量要小得多,因此需要大型随机对照试验检测与新代理之间的差异。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号